Navigation Links
Dynatronics Announces Strong Fourth Quarter Profit
Date:9/14/2007

SALT LAKE CITY, Sept. 14 /PRNewswire-FirstCall/ -- Dynatronics Corporation (Nasdaq: DYNT) today announced results for its fourth quarter and fiscal year ended June 30, 2007. Net income for the fourth quarter increased to $214,943 ($.02 per share), compared to $39,101 ($.00 per share) in the fourth quarter of the previous year. Sales for the quarter were $4,939,425, compared to $4,944,177 in the prior year period.

Sales for the year ended June 30, 2007 were $17,837,104, compared to $19,513,136 in the prior year. Net loss for the year was $85,042 ($.01 per share), compared to net income of $194,031 ($.02 per share) in the prior year.

"We're pleased to see a significant turnaround in the fourth quarter of a challenging year," stated Kelvyn H. Cullimore Jr., company chairman and president. "The strong profit generated in the quarter was largely a result of the introduction of the new Dynatron X5 Oscillation Therapy device during the month of June. In addition, higher Synergie sales and lower R&D expenses contributed to the increase in profits for the quarter."

The X5 unit's gross profit margin as a percent of sales is one of the highest of any of the therapy devices produced by Dynatronics.

"We're encouraged by not only the market demand for the new X5 device, but also by the beneficial outcomes practitioners are achieving with this new modality," said Larry K. Beardall, executive vice president of sales and marketing. "Patients suffering from post-surgical pain or pain due to injury report they are enjoying dramatic improvement from these treatments."

On another front, Beardall reports that the recent acquisition of six of the company's key distributors is generating benefits. "Because the dynamics of the physical medicine market are changing, we moved aggressively to position Dynatronics to compete more effectively within the changing marketplace," he explained. "The vertical integration of these key distributors is providing Dynatronics with direct distribution of our products in 20 states. As a result of these acquisitions, we expect fiscal 2008 revenues to increase 80 percent over fiscal 2007, based on the historical performance of the acquired companies."

"Our strategic plans to reposition the company to be more competitive, together with the new X5 product introduction, are showing great promise for the company's financial future," added Cullimore.

Dynatronics has scheduled a conference call for investors today, Friday, September 14, 2007, at 1 p.m. ET (11:00 a.m. MT). Those wishing to participate should call 800-839-9416 and use passcode 1383812.

A summary of the financial results for the fourth quarter and fiscal year ended June 30, 2007, follows:

Summary Selected Financial Data

Income Statement Highlights

Three Months Ended Twelve Months Ended

June 30, June 30,

2007 2006 2007 2006

Net sales $4,939,425 $4,944,177 $17,837,104 $19,513,136

Cost of sales 2,761,875 3,103,688 10,925,316 12,221,375

Gross profit 2,177,550 1,840,489 6,911,789 7,291,761

SG&A expenses 1,603,167 1,355,064 5,541,860 5,239,462

R&D expenses 339,038 479,952 1,492,774 1,756,281

Other expense, net 18,808 48,445 148,397 86,797

Income (loss) before income

taxes 216,536 (42,971) (271,243) 209,221

Income tax expense

(benefit) 1,593 (82,072) (186,201) 15,190

Net income (loss) $ 214,943 $ 39,101 $ (85,042) $ 194,031

Net income (loss)

per share(diluted) $ .02 $ .00 $ (.01) $ .02

Dynatronics manufactures, markets and distributes advanced-technology medical devices, orthopedic soft goods and supplies, treatment tables and rehabilitation equipment for the physical therapy, sports medicine, chiropractic, podiatry, plastic surgery, dermatology and other related medical, cosmetic and aesthetic markets. More information regarding Dynatronics is available at http://www.dynatronics.com.

This press release contains forward-looking statements. Those statements include references to the company's expectations and similar statements. Actual results may vary from the views expressed in the forward-looking statements contained in this release. The development and sale of the company's products are subject to a number of risks and uncertainties, including, but not limited to, changes in the regulatory environment, competitive factors, availability of third-party component parts and products, inventory risks due to shifts in market demand, changes in product mix, market demand for the company's products and the risk factors listed from time to time in the company's SEC reports including, but not limited to, the report on Form 10-KSB for the year ended June 30, 2006, and its subsequent quarterly reports on Form 10-QSB.


'/>"/>
SOURCE Dynatronics Corporation
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. PM announces a new health care order for India
2. Ramdoss Announces Introduction of RCH-II
3. Britain Announces Third Transfusion Related Mad Cow Case
4. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
5. Tibet Announces the Dalai Lama’s Tour of South Americ
6. NHS announces further Cost cutting Measures
7. Indian PM Announces Of Setting Up India Study Center At Tashkent
8. PowderMed Announces Needle-Less Flu Vaccine
9. Malaysia Announces Prison term On People Donating HIV-Contaminated Blood
10. Australian Government Announces Survey To Tackle Childhood Obesity
11. New Zealand Announces 10-year Plan For Betterment Of Mental Health Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... (PRWEB) , ... April 29, 2016 , ... On Tuesday, ... hospitals across the Southeast, celebrated the signature of Gov. Nathan Deal on SB 258, ... Geoff Duncan (R - Cumming), offers a 70% tax credit to individuals and corporations ...
(Date:4/29/2016)... ... April 29, 2016 , ... The White House ... their loans, more information about their loan terms and accounts, and more protections ... debt, including federal and private loans, has reached $1.3 trillion, with 43 million ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... that infants born with severe congenital diaphragmatic hernia have better survival rates if ... congenital diaphragmatic hernia (CDH)—a condition where the diaphragm fails to form completely, letting ...
(Date:4/29/2016)... ... April 29, 2016 , ... Mobility Designed is ... pressure on the armpits, the M+D Crutch evenly distributes body weight from the elbow ... and hands when using the crutches than with other crutches. , Co-founders Max and ...
(Date:4/29/2016)... Tarzana, CA (PRWEB) , ... April 29, 2016 , ... Melanoma is the deadliest type ... is to blame for the majority of skin cancer deaths. More than 10,000 people are ... average age at diagnosis is 62, it is the one of the most commonly diagnosed ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... , April 28, 2016 TapImmune,Inc. ... of innovative peptide and gene-based immunotherapeutics and vaccines for the ... be presenting at the 3rd Annual Growth Capital Expo ... th , 2016 at Caesars Palace in Las Vegas, Nevada.  ... on Wednesday, May 4 th by Dr. John ...
(Date:4/27/2016)...   , Total ... Consumable Sales  Clinical sales grow 16% year-over-year  ... MKEA, OTCQX: MKEAY) inventor of Cellvizio®, the multidisciplinary confocal ... first quarter ended March 31, 2016 and provided an ... commercial strategy. First Quarter 2016 Revenue Results ...
(Date:4/27/2016)... SHAWNEE, Kan. , April 27, 2016 /PRNewswire/ ... Martabano , a senior from the University of ... winner of the Bayer Excellence in Communication Award ... veterinary schools, which were awarded a total of ... Over the last four years, Bayer has provided ...
Breaking Medicine Technology: